Global Allergic Conjunctivitis Drugs Market – Industry Trends and Forecast to 2030

1. Global Allergic Conjunctivitis Drugs Market – Industry Trends and Forecast to 2030 Allergic Conjunctivitis Drugs Market Analysis and Size It is witnessed that more than 20% of the global population is largely affected by eye condition called allergic conjunctivitis. Even though these symptoms can look like signs of an infection, allergic conjunctivitis is not infectious or contagious. Allergic conjunctivitis is quite common. Treatment for allergic conjunctivitis include oral medications, eye drops or immunotherapy. The increase in prevalence of allergic conjunctivitis is projected to drive the global allergic conjunctivitis market growth during the forecast period. https://www.databridgemarketresearch.com/reports/global-allergic-conjunctivitis-drugs-market The expected CAGR of global hypersensitivity market is tend to be around 5.90% in the mentioned forecast period. The market was valued at USD 3724.2 million in 2022, and it would grow upto USD 5891.16 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

2. Report Description https://www.databridgemarketresearch.com/reports/global-allergic-conjunctivitis-drugs-market Market Definition Allergic conjunctivitis is a type of eye disorder that is characterized by inflammation in the conjunctiva because of allergens, pollen grain, dust mites, cosmetics, chemicals and perfumes. It is also commonly known as pink eye that leads to swell the outer membrane of eyeball. It does not cause any other serious health problems if diagnosed and treated at early stages. The common symptoms include gritty feelings in the eye, abnormal tears amount, itchiness in eyes, thick discharges that form up in the eye during night time and pink or red colour toned eyes. Global Allergic Conjunctivitis Drugs Market Dynamics Drivers Increase in Allergic conjunctivitis The rise in prevalence of allergic conjunctivitis is projected to boost the global allergic conjunctivitis market growth during the forecast period. For instance, according to Clinical Epidemiology and Global Health, in India, the incidence of allergic conjunctivitis was around 12.22%, whereas allergic conjunctivitis was recorded in more males (13.44%) compared to females (10.71%) in 2019. This boost the market growth. Growing R&D Activities Major market players operating in the market are focusing on the development of treatments for allergic conjunctivitis, this is projected to boost the global allergic conjunctivitis market growth during the forecast period. For instance, in April 2020, Ocular Therapeutix, Inc., a biopharmaceutical company focused on the development, formulation, and commercialization of innovative therapies for diseases and conditions of the eye, declared topline results from its Phase 3 clinical trial to assess the safety and efficacy of DEXTENZA used for the treatment of ocular itching related with allergic conjunctivitis (AC).

3. Market Overview Opportunities Higher Growth on Product Launches Major market players operating in the global allergic conjunctivitis market are primarily focusing on adoption of growth strategies such as product launch, regulatory approval, and R&D for the treatment of allergic conjunctivitis, that are expected to drive the market growth during the forecast period. For instance, in March 2020, Eyevance Pharmaceuticals, a provider of ophthalmic products and therapies intended to address unmet medical needs, announced the U.S. launch of Zerviate 0.24% for treating ocular itching related with allergic conjunctivitis. Increasing Demand for Retail Pharmacies:  Restraints/Challenges Lack of skilled professionals The lack of qualified healthcare professional unable to treat the patients with appropriate eye lubricants could restrain the growth of the global allergic conjunctivitis drugs market over a forecast period. Risk of Side-Effects This global allergic conjunctivitis drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global allergic conjunctivitis drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

4. Key Players • Key players operating in the global allergic conjunctivitis drugs market include: • Merck & Co. Inc. (U.S.) • Pfizer Inc. (U.S.) • Teva Pharmaceutical Industries Ltd. (Israel) • Bayer AG (Germany) • Novartis AG (Switzerland) • Endo International plc (Ireland) • Lupin (India) • CiplaInc (India) • Akorn Operating Company (U.S.) • Bausch &Lomb (Canada) • Perrigo Company plc (Ireland) • Hoffmann-La Roche Ltd (Switzerland) • AbbVie Inc. (U.S.) • Bausch Health Companies Inc. (Canada)

5. About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Read Continue : http://databridgemarketresearch.com/about-us/ Contact Us : SopanGedam Sopan.gedam@databridgemarketresearch.com